Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | USP1 | O94782 | 17/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2210780 | 0.84 | ADORA3 (0.62) | ADORA3USP1 | |
| SCHEMBL7215331 | 0.79 | ADORA3 (0.68) | ADORA3USP1 | |
| SCHEMBL7215568 | 0.78 | ADORA3 (0.55) | ADORA3USP1 | |
| SCHEMBL7210956 | 0.77 | ADORA3 (0.65) | ADORA3USP1KDM4EALDH1A1 | |
| SCHEMBL7210910 | 0.77 | ADORA3 (0.84) | ADORA3USP1 | |
| SCHEMBL15157018 | 0.76 | DAO (0.49) | USP1KDM4EALDH1A1 | |
| SCHEMBL27887734 | 0.75 | TSPO (0.56) | ADORA3USP1 | |
| SCHEMBL3311829 | 0.73 | CYP1A2 (0.57) | ADORA3KDM4EALDH1A1 | |
| SCHEMBL3591401 | 0.73 | MEN1 (0.55) | KDM4EALDH1A1 | |
| SCHEMBL7212031 | 0.72 | ADORA3 (0.58) | ADORA3USP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005560-A1 | PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS | AJINOMOTO CO. INC (JP) | 2009-01-01 | — | — | US | disclosed |
| EP-2009003-A1 | Production method of diaminopyrimidine compounds | Ajinomoto Co., Inc. (JP) | 2008-12-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005560-A1 | PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS | DPYD, DHPS, UMPS | ADORA3 1282/4885USP1 4482/4885KDM4E 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.